Zyprexa

Among newer products, sales of Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera Symbyax, Xigris and Yentreve made up $791.2 million of fourth-quarter sales, or 20% of the total, up from 14% a year ago.

Caterpillar Rolls (TheStreet.com) Baxter Profit Tops Forecast (TheStreet.com) Verizon Hits Targets (TheStreet.com) Microsoft's Zen Moment (TheStreet.com) S&P Testing a Low or Preparing to Bail?

(RealMoney.com) History Repeating (The Trading Reports) A Rock and a Hard Place (The Daily Swing Trade) Key Themes in Telecom (The Telecom Connection) Special After-Hours Update (ActionAlertsPLUS) Chips May Not Stay Down (RealMoney.com) Johnson & Johnson Won't Be Down Long (RealMoney.com) Reality Check on Latin America Investing (RealMoney.com) Favorable Trends (TheStreet.com Stocks Under $10) Trade Triggers (TheStreet.com Technology Report) Earnings May Derail This Stock (Options Alerts) Finding the Good in a Bad Week (Internet Review Weekly Newsletter) Write us!

Order reprints of TSC articles.

Top Investor Relations Contact Us Subscribe to our RSS Feed Subscribe to our PODCAST © 1996- TheStr...

Read more...